$四環醫藥(00460.HK)$ From the chart, it should be on 2nd-wave rebounce, if so it should going to enter 3rd-wave. Today news show it having good revenue in report, but how come it falls to 0.53? Because of touching 61.8% fibonacci? Hmm... Interesting.
Concerns exist about Sihuan Pharmaceutical's future ability to maintain a healthy balance sheet given continuous losses and sinking revenue. The absence of free cashflow adds uncertainty to its risk level.
102326032 : 專業
投智者KT樓主 102326032: 它不是...查姆..
102326032 : 太棒了,不明白哈哈
102326032 : 所以你擁有這股票?
投智者KT樓主 102326032: 是的。我期待會發生
查看更多評論...